Paper486305
Distribution of misonidazole in human tumours and normal tissues.
Ash DV and 2 others. Br J Cancer, 1979. Cited by 48 papers, by iCite.
Cite this record
ConductScience Library. Distribution of misonidazole in human tumours and normal tissues. Papers, record 486305. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/486305
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Misonidazole | Major topic |
| Neoplasms | Major topic |
| Nitroimidazoles | Major topic |
| Brain Neoplasms | |
| Breast Neoplasms | |
| Female | |
| Genital Neoplasms, Female | |
| Humans | |
| Male | |
| Thyroid Diseases | |
| Tissue Distribution | |
| Urinary Bladder Neoplasms |
Source PubMed
References5
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 273269 | Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer. | Radiat Res | 1978 | https://conductscience.org/library/papers/273269 | PubMed |
| 2 | 444398 | Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice. | Br J Cancer | 1979 | https://conductscience.org/library/papers/444398 | PubMed |
| 3 | 659541 | Estimation of the hypoxic cell-sensitiser misonidazole and its O-demethylated metabolite in biological materials by reversed-phase high-performance liquid chromatography. | J Chromatogr | 1978 | https://conductscience.org/library/papers/659541 | PubMed |
| 4 | 841074 | Clinical phase I study of the hypoxic cell radiosensitizer RO-07-0582, a 2-nitroimidazole derivative. | Radiology | 1977 | https://conductscience.org/library/papers/841074 | PubMed |
| 5 | 776493 | Clinical testing of the radiosensitiser Ro-07-0582. I. Dose tolerance, serum and tumour concentrations. | Clin Radiol | 1976 | https://conductscience.org/library/papers/776493 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7370171 | Mitochondrial alterations produced by misonidazole: a study using Amoeba proteus as a single-cell model. | Br J Cancer | 1980 | https://conductscience.org/library/papers/7370171 | PubMed |
| 7370170 | Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity. | Br J Cancer | 1980 | https://conductscience.org/library/papers/7370170 | PubMed |
| 7370166 | Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs. | Br J Cancer | 1980 | https://conductscience.org/library/papers/7370166 | PubMed |
| 7295516 | Phenytoin-induced changes in the pharmacokinetics of misonidazole in radiotherapy patients. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7295516 | PubMed |
| 7248155 | Transition from laboratory to clinic in cancer treatment. Abstracts of symposium papers. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7248155 | PubMed |
| 7225285 | The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7225285 | PubMed |
| 7190019 | Combination studies with misonidazole and a cis-platinum complex: cytotoxicity and radiosensitization in vitro. | Br J Cancer | 1980 | https://conductscience.org/library/papers/7190019 | PubMed |
| 7172406 | Absorption and distribution of vaginally administered misonidazole. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/7172406 | PubMed |
| 7059476 | The penetration of misonidazole into a mature structural cartilage. | Br J Cancer | 1982 | https://conductscience.org/library/papers/7059476 | PubMed |
| 7016157 | A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7016157 | PubMed |
| 7013776 | Low concentrations of misonidazole counteract effects of extreme hypoxia on cells in S. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7013776 | PubMed |
| 6932924 | Growth delay studies in patients with multiple metastases. | Br J Cancer Suppl | 1980 | https://conductscience.org/library/papers/6932924 | PubMed |
| 3719893 | Distribution and tumor penetration properties of a radiosensitizer 2-[14C] misonidazole (Ro 07-0582), in mice and rats as studied by whole-body autoradiography. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3719893 | PubMed |
| 3677296 | Distribution of nitroimidazoles and L-phenylalanine mustard in mammary adenocarcinoma 16/C tumors. | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/3677296 | PubMed |
| 2757919 | Microscopic distribution of misonidazole in mouse tissues. | Br J Cancer | 1989 | https://conductscience.org/library/papers/2757919 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/486305
GET https://conductscience.org/api/papers/v1/486305/authors